SecBot SecBot
PRESS-RELEASE ·Filed Mar 4, 2026

RDNT

RadNet, Inc.
BULLISH
Impact 7/10
Horizonweeks Processed8mo ago WireGlobeNewswire
Press release · M&A
Actionable Insight ▲ Bullish

Traders should monitor the March 5 call for details on synergies, revenue potential from expanded AI offerings, and management's outlook for the DeepHealth segment. The integration of Gleamer could accelerate RadNet's transition into high-margin digital health services.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$71.33
T+0 close · Mar 4, 2026 · via day close
Latest settled
−22.46%
T+60 · $55.31
Vs SPY
−32.55%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 4 $71.33entry
  2. T+1 · 9mo ago −6.53%α −5.96% · $66.67
  3. T+5 · 8mo ago −14.20%α −12.87% · $61.20
  4. T+20 · 8mo ago −22.46%α −18.04% · $55.31
  5. T+60 · 6mo ago −22.46%α −32.55% · $55.31
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

RadNet, Inc. is hosting an investor call to discuss its recently completed acquisition of Gleamer SAS, a France-based AI medical imaging company, and its broader Digital Health strategy under the DeepHealth brand. The acquisition enhances RadNet's AI-powered diagnostic capabilities across imaging modalities, including X-ray, mammography, CT, and MRI, with Gleamer having analyzed over 30 million exams globally.

Key Facts

  • RadNet completed the acquisition of Gleamer SAS, an AI medical imaging company founded in 2017.
  • Gleamer’s AI solutions support radiologists in diagnosing across X-ray, mammography, CT, and MRI.
  • Gleamer has analyzed over 30 million exams across 2,250 locations in 44 countries.
  • 60 peer-reviewed publications validate the performance of Gleamer’s AI tools.
  • Investor call on March 5, 2026, will detail the integration and RadNet’s Digital Health strategy under DeepHealth.

Financial Impact

Strategic enhancement of RadNet's AI capabilities; specific deal value not disclosed but likely material given Gleamer's global footprint and technology portfolio.

digital_health_revenueoperating_efficiencyai_product_offering

Risk Factors

  • Integration risk in combining Gleamer’s technology and operations into RadNet’s existing platform.
  • Regulatory or reimbursement challenges for AI-driven diagnostic tools in key markets.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3249150

US Market Status

Market Closed · Opens Wed (13h 31m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 4, 2026